jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 22, 2014

Dec. 17, 2018

jRCT2080222468

A phase 2, double-blind, randomized, safety and efficacy study of GE-145 versus Iodixanol in subjects undergoing peripheral angiography.

version:
date:

DAIICHISANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html

100

Interventional

2

The subjects who will undergo peripheral angiography with or without elective PPI.

No limit
No limit

Both

The subjects undergoing peripheral angiography

investigational material(s)
Generic name etc : GE-145
INN of investigational material : Ioforminol (INN)
Therapeutic category code : 721 X-ray contrast agents
Dosage and Administration for Investigational material : Injection

control material(s)
Generic name etc : Iodixanol
INN of investigational material : Iodixanol (INN)
Therapeutic category code : 721 X-ray contrast agents
Dosage and Administration for Investigational material : Injection

Image quality
Evaluation based on a criteria

Safety
Adverse events after the administration of the study drug

DAIICHISANKYO Co.,Ltd.

JapicCTI-142518

History of Changes

No Publication date
5 Dec. 17, 2018 (this page) Changes
4 May. 18, 2015 Detail Changes
3 May. 18, 2015 Detail Changes
2 April. 22, 2014 Detail Changes
1 April. 22, 2014 Detail